AmiKana.BioLogics
Marseille
About AmiKana.BioLogics
AmiKana.BioLogics is a biotech company, provides tools for drug resistance analysis yeast cells. Its products include drug resistance diagnostic kits for clinical applications; and a product that targets analysis of viral resistance to HIV-1 protease and reverse transcriptase inhibitors.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $268.7K
- Funding stage: Seed
- Last round: Seed (Nov 2012)
- Website: amkbiol.com
- Phone: +33 4 91 32 46 40
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amikana-biologics-986064 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.